Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 4081-4090 of 13612

Page
per page
  1. tetranor-PGEM
    C5184 tetranor-PGEM
    Summary: A prostaglandin E2 metabolite for evaluating inflammation- and cancer-related biomarkers.
      ≤50 mg/mL
  2. MIND4-19
    BA4524 MIND4-19
    Summary: MIND4-19 is a potent inhibitor.
  3. Phenosafranine
    C8297 Phenosafranine
    Summary: Phenosafranine is a phenazine dye.
  4. Boc-N-Me-Phg-OH
    A7710 Boc-N-Me-Phg-OH
  5. KS106
    BA2987 KS106
    Summary: KS106 is a potent inhibitor.
  6. 4-Aminobenzoic acid hydrazide
    C5175 4-Aminobenzoic acid hydrazide
    Summary: An irreversible covalent MPO inhibitor for stroke research.
      ≥63.2 mg/mL
      ≥5.85 mg/mL
  7. 4-Methylumbelliferyl-2-acetamido-2-deoxy-β-D-Glucopyranoside
    C8296 4-Methylumbelliferyl-2-acetamido-2-deoxy-β-D-Glucopyranoside
    Summary: It is a fluorescent substrate for N-acetyl-β-D-glucosaminidase.
  8. Z-N-Me-Phe-OH
    A7709 Z-N-Me-Phe-OH
  9. Zoliflodacin
    BA1032 Zoliflodacin
    Summary: A novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor with broad-spectrum antibacterial activity for bacterial infection
      ≥52 mg/mL
  10. CDK9-IN-7
    BA2986 CDK9-IN-7
    Summary: CDK9-IN-7 is a highly potent and selective, orally active inhibitor.

Items 4081-4090 of 13612

Page
per page